.

LPL - LPL-ROHINI (NATIONAL

REFERENCE LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Z780 Collected : 28/7/2020 12:43:00PM

Received : 28/7/2020 2:37:45PM
Lab No. : 153672148 Age: 35 Years Gender: Female Reported : 13/8/2020 12:20:34PM
A/c Status : P Ref By : UNKNOWN Report Status : Final

Test Name Results Units Ref. Range

LEUKEMIA DIAGNOSTIC PANEL: PLASMA CELL DYSCRASIA

(Flow Cytometry)

MARKERS RESULT (%) INTENSITY INTERPRETATION

CD45 0.3 Negative Negative
CD19 0.1 Negative Negative
CD20 0.0 Negative Negative
CD27 48.3 Partial Dim Positive
CD38 98.2 Bright Positive
CD138 76.0 Dim to Mod Positive
CD38 and CD138 co expression 76.0 Mod to Bright Positive
Kappa (Cyto) 88.0 Dim pos Positive
Lambda (Cyto) 0.12 Negative Negative
CD56 89.2 Mod to Bright Positive
CD117 76.0 Dim to Mod Positive
CD200 91.0 Dim to Mod Positive

Instrument : FACSCanto II

Software : Diva

Cell Preparation Method : Stain Lyse wash

Type of Specimen : Bone Marrow

Percent Viability : 85.0

Percentage cells gated : 45.0

Gating strategy : CD38 bright vs. low SSC, CD45 vs. CD38/CD138

Comments:
CBC not received. TLC (done on sample provided)-32,000/ul.
Clinical history not received.
PatientReportSCSuperPanel.FLOWCYTO_SC_NEW (Version: 3)

*153672148*
Page 1 of 2
.

LPL - LPL-ROHINI (NATIONAL

REFERENCE LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Z780 Collected : 28/7/2020 12:43:00PM

Received : 28/7/2020 2:37:45PM
Lab No. : 153672148 Age: 35 Years Gender: Female Reported : 13/8/2020 12:20:34PM
A/c Status : P Ref By : UNKNOWN Report Status : Final

Test Name Results Units Ref. Range

Findings:
Flow cytometric analysis reveals a distinct population (45% of the total) of atypical cells/plasma cells, which
are negative for CD45, CD19 and CD20. These cells show kappa light chain (cytoplasmic) restriction, co
express CD38 and CD138 and are positive for CD56, CD200, CD117 and CD27 (subset). Of the remaining
cells, 2% are lymphoid, 52% are granular myeloid and 1% are erythroid/debris.

Impression:
The flow cytometric findings are suggestive of a plasma cell neoplasm with 45% atypical cells with
plasma cell immunophenotype. However, it is highly recommended to correlate with serum protein
electrophoresis and immunofixation studies. Correlation with clinical features, peripheral blood findings and
bone marrow morphology is essential for final conclusion.

This test was developed and its performance characteristics determined by LPL .

Dr Anand Chandrasekaran Annan Dr Beena Chandrasekhar

MD (American Board of Pathology) PhD, Life Sciences
PhD (Molecular & Cellular Pathology) HOD Flowcytometry
HOD - Oncopathology NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

IMPORTANT INSTRUCTIONS

*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
*Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
customer care Tel No. +91-11-39885050 for all queries related to test results.
(#) Sample drawn from outside source.

PatientReportSCSuperPanel.FLOWCYTO_SC_NEW (Version: 3)

*153672148*
Page 2 of 2